<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC5878019/results/search/disease/results.xml">
  <result pre="Background and aim Riboflavin may have an acceptable effect on" exact="migraine" post="among children. This study was carried out to determine"/>
  <result pre="carried out to determine the prophylactic effect of riboflavin on" exact="migraine" post="in children. Methods This randomized clinical trial study was"/>
  <result pre="Iran from December 2012 to February 2015. Ninety children with" exact="migraine" post="were allocated randomly into 3 groups (placebo, low-dose and"/>
  <result pre="for statistical analyses. Results There was a significant decrease of" exact="migraine" post="frequency (p=0.000) and mean duration (p=0.000) in the high-dose"/>
  <result pre="(p=0.49 and p=0.69 respectively). There was no significant reduction of" exact="migraine" post="intensity in the low-dose and high-dose groups compared to"/>
  <result pre="23% in adolescents ( 1). Occasionally, frequency and severity of" exact="migraine" post="become overwhelming which cause disturbance of life quality and"/>
  <result pre="3). The safety of many prophylactic drugs in adults with" exact="migraine" post="has not been tested completely on children, so symptomatic"/>
  <result pre="that has been documented as an effective prophylactic agent for" exact="migraine" post="( 2). Nevertheless, in spite of various drugs, no"/>
  <result pre="Drug Administration (FDA) approved medication is recommended for prophylaxis of" exact="migraine" post="in children ( 8). Riboflavin is involved in the"/>
  <result pre="that suggest the efficacy of high-dose riboflavin (400 mg/day) for" exact="migraine" post="prevention in adults ( 14– 16), and doses of"/>
  <result pre="randomized, placebo-controlled trial showed no effect of high-dose riboflavin on" exact="migraine" post="prophylaxis in children ( 13, 17). Another study on"/>
  <result pre="on 8 to 18-year-old children in Italy indicated decrease of" exact="migraine" post="frequency and intensity by riboflavin ( 1). The side-effects"/>
  <result pre="The side-effects of riboflavin have been shown as minimal, including" exact="diarrhea" post="and polyuria (1 out of 43 adults). The most"/>
  <result pre="substantial controversy about the effectiveness of riboflavin in children with" exact="migraine" post="and a few side effects of it, we decided"/>
  <result pre="and high dose riboflavin on intensity, duration and frequency of" exact="migraine" post="2. Material and Methods 2.1. Study design and participants"/>
  <result pre="were filled. The questions covered different areas including age, sex," exact="migraine" post="with and without aura, months passed since onset of"/>
  <result pre="aura, months passed since onset of migraine, family history of" exact="migraine" post="and mean intensity, frequency and duration of headache in"/>
  <result pre="our trial. Diagnoses were made based on diagnostic criteria for" exact="migraine" post="with or without aura and tension headaches present in"/>
  <result pre="per month. Exclusion criteria were: 1- severe neurologic disorders or" exact="epilepsy" post="2- liver, kidney, gastrointestinal, cardiovascular or metabolic disorders 3-"/>
  <result pre="hours daily. The parents and children received data concerning childhood" exact="migraine" post="( 3) and the patients consumed acetaminophen or ibuprofen"/>
  <result pre="2 shows the mean (SD) frequency, duration and intensity of" exact="migraine" post="attacks at baseline and the end of riboflavin prophylaxis"/>
  <result pre="of frequency attacks (p=0.49), but there was significant decrease of" exact="migraine" post="frequency in the high-dose group compared with the placebo"/>
  <result pre="and 24 (80%) patients had 50% or more decrease in" exact="migraine" post="frequency in the placebo, low dose and high dose"/>
  <result pre="dose groups respectively (p=0.000). There was no significant diminution of" exact="migraine" post="intensity in low-dose and high-dose groups in comparison to"/>
  <result pre="Meanwhile, there was a dramatic shortening of mean duration of" exact="migraine" post="attacks among the high-dose group individuals compared to those"/>
  <result pre="Also, there was a marked decline in mean duration of" exact="migraine" post="attacks in the high-dose group compared with the low-dose"/>
  <result pre="comparison with the low-dose group (p=0.000). No significant reduction of" exact="migraine" post="intensity was seen among the high-dose group compared to"/>
  <result pre="Discussion The present study showed that riboflavin prophylaxis significantly reduces" exact="migraine" post="duration and frequency, but not the intensity. These data"/>
  <result pre="mg/day riboflavin was not effective on frequency and severity of" exact="migraine" post="attacks ( 17) which is inconsistent with our study,"/>
  <result pre="to the fact that no upper limit ( 19) for" exact="migraine" post="frequency (15 or more attacks per month is indicative"/>
  <result pre="our study. Condo et al. showed that riboflavin prophylaxis reduced" exact="migraine" post="intensity and frequency, and this is compatible with our"/>
  <result pre="intensity ( 1). Notably, they found a significant reduction of" exact="migraine" post="frequency among children less than 12 years of age"/>
  <result pre="than 12 years of age and a substantial decrease of" exact="migraine" post="intensity in males ( 1). It seems that age"/>
  <result pre="between age and sex and effect of riboflavin treatment on" exact="migraine" post="intensity and frequency. Some adult studies have suggested that"/>
  <result pre="frequency. Some adult studies have suggested that riboflavin prophylaxis diminishes" exact="migraine" post="frequency but not migraine intensity, and this is congruent"/>
  <result pre="have suggested that riboflavin prophylaxis diminishes migraine frequency but not" exact="migraine" post="intensity, and this is congruent with our results ("/>
  <result pre="Nevertheless, no effect was reported on frequency and duration of" exact="migraine" post="( 13). Probably due to use of low- dose"/>
  <result pre="dose between 100 to 400 mg daily in children with" exact="migraine" post="seems to be safe for several months ( 12)."/>
  <result pre="its use could be recommended to parents of children with" exact="migraine" post="who have financial restrictions. Some limitations of our investigation"/>
  <result pre="be about 4 months ( 1). 2- Upper limit for" exact="migraine" post="frequency as an exclusion criterion was not ascertained. 3-"/>
  <result pre="indicates that high-dose riboflavin decreases the frequency and duration of" exact="migraine" post="attacks in children, with no side effects. The practical"/>
  <result pre="It is recommended that high dose riboflavin be used for" exact="migraine" post="prophylaxis among children. Further studies with larger sample sizes"/>
  <result pre="Arbizzani A Parmeggiani A Riboflavin prophylaxis in pediatric and adolescent" exact="migraine" post="J Headache Pain 2009 10 5 361 5 10.1007/s10194-009-0142-2"/>
  <result pre="al. Efficacy and safety of cinnarizine in the prophylaxis of" exact="migraine" post="in children: a double-blind placebo-controlled randomized trial Pediatr Neurol"/>
  <result pre="D Yonker M Silberstein S Practice parameter: pharmacological treatment of" exact="migraine" post="headache in children and adolescents: report of the American"/>
  <result pre="Wroolie TE Topiramate: Effects on cognition in patients with epilepsy," exact="migraine" post="headache and obesity Ther Adv Neurol Disord 2013 6"/>
  <result pre="Effects on cognition in patients with epilepsy, migraine headache and" exact="obesity" post="Ther Adv Neurol Disord 2013 6 4 211 27"/>
  <result pre="Bolzonella B Sartori S Battistella PA The pharmacological treatment of" exact="migraine" post="in children and adolescents: an overview Expert Rev Neurother"/>
  <result pre="11 Sherwood M Goldman RD Effectiveness of riboflavin in pediatric" exact="migraine" post="prevention Can Fam Physician 2014 60 3 244 6"/>
  <result pre="Einhaupl KM Arnold G High-dose riboflavin treatment is efficacious in" exact="migraine" post="prophylaxis: an open study in a tertiary care centre"/>
  <result pre="Burchette R A combination of riboflavin, magnesium, and feverfew for" exact="migraine" post="prophylaxis: a randomized trial Headache 2004 44 9 885"/>
  <result pre="J Jacquy J Lenaerts M Effectiveness of high-dose riboflavin in" exact="migraine" post="prophylaxis. A randomized controlled trial Neurology 1998 50 2"/>
  <result pre="KM Ratanayake PD Fagan E Antony J High-dose riboflavin for" exact="migraine" post="prophylaxis in children: a double-blind, randomized, placebo-controlled trial J"/>
  <result pre="A Luchetti A Paolino MC Villa MP Melatonin to prevent" exact="migraine" post="or tension-type headache in children Neurol Sci 2008 29"/>
  <result pre="(50) 19 (63.3) 19 (63.3) 0.38 Months since onset of" exact="migraine" post="(mean ± SD) 29.33±15.54 25.37±14.69 22.77±12.33 0.21 Frequency of"/>
  <result pre="migraine (mean ± SD) 29.33±15.54 25.37±14.69 22.77±12.33 0.21 Frequency of" exact="migraine" post="per month (mean ± SD) 8.20±3.25 7.83±3.83 9.27±3.03 0.24"/>
  <result pre="month (mean ± SD) 8.20±3.25 7.83±3.83 9.27±3.03 0.24 Duration of" exact="migraine" post="in hours (mean ± SD) 7.97±2.92 6.97±2.62 7.90±3.03 0.36"/>
  <result pre="hours (mean ± SD) 7.97±2.92 6.97±2.62 7.90±3.03 0.36 Intensity of" exact="migraine" post="in degree (Likert scale) (mean ± SD) 2.30±0.47 2.37±0.49"/>
  <result pre="0.72 Table 2 Mean (SD) frequency, duration and intensity of" exact="migraine" post="attacks at baseline and end of riboflavin prophylaxis and"/>
  <result pre="(baseline); Wk. 12, week 12 (end); Frequency, frequency (number) of" exact="migraine" post="attacks monthly; Duration, mean duration of migraine attacks in"/>
  <result pre="frequency (number) of migraine attacks monthly; Duration, mean duration of" exact="migraine" post="attacks in hours monthly; Intensity, mean intensity of migraine"/>
  <result pre="of migraine attacks in hours monthly; Intensity, mean intensity of" exact="migraine" post="attacks in degree monthly; Decrease, decrease of headache items"/>
 </snippets>
</snippetsTree>
